Promising targets to counteract DMD progression also include strategies to inhibit nuclear factor-kappaB (NF-kappaB), transforming growth factor-alpha (TGF-alpha), transforming growth factor-beta (TGF-beta) and inhibiting the production or action myostatin [39]. This evidence concerns the gene TGFA and Duchenne muscular dystrophy.